Visit the Beamex web site
Click on the advert above to visit the company web site

Product category: Pharmaceutical Processing News
News Release from: Smithers Rapra
Edited by the Processingtalk Editorial Team on 02 September 2005

Rapra will be on show at PABORD 05

Request your FREE weekly copy of the Processingtalk email newsletter. News about Pharmaceutical Processing News and more every issue. Click here for details.

Rapra Technology will show their pharmaceutical industry capabilities at PABORD 05, the 2nd International Pharmaceutical and Biotech Outsourcing Research and Development Exhibition and Conference

Rapra Technology, Europe's leading research and test centre for plastics and rubber, will be exhibiting its services and consultancy for the worldwide pharmaceutical industry at PABORD 05, the 2nd International Pharmaceutical and Biotech Outsourcing Research and Development Exhibition and Conference The exhibition will take place in the Olympia Exhibition Halls in London from 14-15 September, where the new Rapra Pharma brand will formally be launched

"There is an undeniable volume growth in the amount of polymeric material and product knowledge - analysis, testing and validation - now needed by the pharmaceutical and biotech industries, - notes David Ingles, Manager for the Rapra Technology Sales Group.

'Our recent sales in this market have proved the need for attending an exhibition such as PABORD and have validated the use and need for a Rapra Pharma brand.

We will be playing a full part at Olympia to show our pharmaceutical and biotech visitors a complete 'one-stop-shop' for all their outsourcing needs in plastics technology related matters; in packaging contact issues, for example, and in product and materials analysis, design and testing'.

Ingles says that 'pharmaceutical companies, quite rightly, want to stick to what they know in terms of drug research and design.

They also want to let specialist suppliers such as ourselves take on a package of outsourced technical business further downstream.

It is essential that these sub-contractors not only have experience in dealing with the pharmaceutical world but can operate to the level of quality demanded within the timescales imposed by clients.

Rapra has a proven track record in this area and has positioned itself as the polymer outsource partner of choice'.

Developing regulations in Europe now make it compulsory, for example, for extractables and leachables studies to be carried out on new pharmaceutical products.

This kind of outsourced work is now steadily increasing at Rapra Technology.

Ingles notes that 'our highly qualified and specialist teams at Rapra are able to give our clients best advice, practice and compliance through scientific method and validation - specifically with the appropriate studies, according to FDA/CDER guidelines.

We are also able to offer a method development and validation services for clients'.

Further details of these and other Rapra Technology services for pharmaceuticals, and the Rapra presence at PABORD 05 contact David Ingles at Rapra Technology.

Smithers Rapra: contact details and other news
Email this article to a colleague
Register for the free Processingtalk email newsletter
Processingtalk Home Page

Search the Pro-Talk network of sites

Visit the Beamex web site